Company Update: Allergan Inc (NYSE:AGN) – Allergan Breaks Ground on $200 Million Waco Facility Expansion

[PR Newswire] – WACO, Texas, April 25, 2016 /PRNewswire/ — Allergan plc (AGN), a leading global pharmaceutical company, today broke ground on a $200 million expansion of its Waco, Texas facility. “This investment will add highly-skilled jobs to the Waco and Central Texas economies, elevate our manufacturing capabilities and increase our ability to provide more complex medicines to more physicians and their patients around the globe. Read more on this. Allergan plc (AGN) , currently valued at $88.84B, began trading this morning at $228.12. Shares have traded today between $223.85 and $228.45 per share with a trailing 52-week range being $212.67 to $340.34. AGN shares are currently priced at 16.10x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -6.63x earnings multiple for the same period. And for passive income investors, the company pays shareholders $0.20 per share annually in dividends, yielding 0.10%. In a review of the consensus earnings estimate this quarter, 19 sell-side analysts are looking at $3.04 per share, which would be $1.26 worse than the year-ago quarter and a $0.61 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $14.23 is a $0.80 better when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $3.96 Billion. If realized, that would be a 5.71% decrease over the year-ago quarter. Recently, Guggenheim Initiated AGN at Neutral (Apr 18, 2016). Previously, Piper Jaffray downgraded AGN from Overweight to Neutral. With the above information in mind, readers should note that the average price target is $297.72, which is 30.51% above where the stock opened this morning. See more in (NYSE:AGN) Similar Articles: Company Update: Allergan Inc (NYSE:AGN) – Allergan, Pfizer call off $US160B deal Company Update: Allergan Inc (NYSE:AGN) – Allergan Presents Data at the 2016 American Academy of Dermatology (AAD) Annual Meeting in Washington D.C. Stock Update: Allergan Inc (NYSE:AGN) – Independent Baylor University Study Showcases Economic Impact of Allergan on Waco and Central Texas Economies